Arcutis Biotherapeutics, Inc. $ARQT Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase and Co. decreased its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) by 81.6% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm owned 100,794 shares of the company's stock after selling 447,995 shares during the period. JPMorgan Chase and Co. owned